Navigation Links
Misonix to Present at the MDB Capital Bright Lights Conference on May 11, 2011
Date:5/4/2011

FARMINGDALE, N.Y., May 4, 2011 /PRNewswire/ -- Misonix, Inc. (NASDAQ: MSON), a medical device company that designs, manufactures, and markets innovative, therapeutic, ultrasonic products worldwide for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications, announced today that it will present at the MDB Capital Bright Lights Conference on Wednesday, May 11, 2011 at the Le Parker Meridien Hotel in New York City.  Michael A. McManus, Jr., President and Chief Executive Officer, will address the conference at 11:30 AM Eastern time to discuss the Company's business strategy and historical financial performance.

Bright Lights is the only conference of its kind with an exclusive focus on publicly-traded companies with market changing intellectual property (IP).

Misonix was selected from MDB's 2011 group of "Best and Brightest" small-cap companies; a group that is advancing some of today's most innovative and market-leading IP.  Misonix is one of the 40 public companies ranking in the 90th percentile for its respective technology leadership from more than 1,500 small-cap companies with granted U.S. patents, as rated by PatentVest, MDB's proprietary IP business intelligence platform.

To learn more about the event, please visit: http://www.mdb.com

About MDB Capital Group

MDB Capital Group, LLC is an institutional research and investment banking firm focusing exclusively on small and micro-cap companies possessing market changing, disruptive intellectual property.  For more information on MDB Capital Group, visit:  http://www.mdb.com

About PatentVest

PatenVest® is a proprietary intellectual property (IP) business intelligence platform developed by MDB Capital Group. PatentVest quantifies the appropriate valuation of IP and enables the emergence of IP as an investible asset class. For more information on PatentVest visit: http://www.patentvest.com

About Misonix:

Misonix, Inc. designs, manufactures and markets therapeutic ultrasonic medical devices. Misonix's therapeutic ultrasonic platform is the basis for several innovative medical technologies. Addressing a combined market estimated to be in excess of $3 billion annually; Misonix's proprietary ultrasonic medical devices are used for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications.  Additional information is available on the Company's Web site at www.misonix.com.

Investor Relations Contact:
Kevin McGrath, Cameron Associates, Inc.
212-245-4577
Kevin@cameronassoc.com


'/>"/>
SOURCE Misonix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Misonix Exhibits at Annual APTA-CSM Meeting
2. Misonix Announces New Distribution Agreement for Colombia
3. Misonix Announces Change in Distribution of BoneScalpel™ Bone Cutting System in the U.S.
4. Misonix to Present at the ROTH Capital Growth Stock Conference on March 15, 2011
5. Misonix Reports Second Quarter and Six Months Fiscal 2011 Financial Results
6. Misonix Announces Completion of Product Registrations in Key Latin American Markets
7. Misonix Schedules Second Quarter 2011 Financial Results Conference Call; February 9, 2011 at 4:30 p.m. Eastern
8. Misonix to Present at Sidoti & Company 2011 Micro Cap Conference
9. Misonix Announces Achievement of Contract Vendor Status With Select Medical Corporation
10. Misonix Previews New OsteoSculpt® Ultrasonic Bone Scalpel
11. Misonix Reports First Quarter Fiscal 2011 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... , May 25, 2016 MedDay, a ... announces that an oral presentation entitled "High doses of biotin ... trial" will be given by Professor Ayman Tourbah , ... Congress of the European Academy of Neurology (EAN) in ... related disorders 3" will take place on Sunday, 29 May ...
(Date:5/24/2016)... , May 24, 2016 ... beide primären Endpunkte und ... Überlegenheit in ‚ausgezeichneter plus guter ... Colons    ,      (Logo: ... gab heute neue positive Daten von der MORA-Studie ...
(Date:5/24/2016)... Celsion Corporation (NASDAQ: CLSN ... an update on its ongoing OVATION study, a ... the Company,s DNA-based immunotherapy, with the standard of ... advanced ovarian cancer who will undergo neoadjuvant chemotherapy ... IL-12 DNA plasmid vector formulated as a nanoparticle ...
Breaking Medicine Technology:
(Date:5/27/2016)... ... 2016 , ... W.S. Badger Co. Inc ., the maker of certified ... as one of the best small businesses for new dads by Fatherly, the digital ... businesses providing progressive benefits to new parents on the organization’s 2016 Best Places ...
(Date:5/27/2016)... ... May 27, 2016 , ... An educational campaign aimed at ... stories, courtesy of awareness-driven celebrities and thought leaders. It also provides insight to ... industry leaders such as Bioness. , As patients feel increasingly concerned about ...
(Date:5/27/2016)... ... 27, 2016 , ... Aimed at nurses and employees in the health care ... leaders in the nursing and health care industry. It also provides insight to the ... University. , As the nursing industry is coming out of one of the ...
(Date:5/26/2016)... ... , ... There are many ways to cook a hot dog, but new ... prefer their dogs straight off the grill. Of the 90 percent of Americans who ... cook a hot dog, far outpacing other cooking methods such as steaming (12 percent), ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... property (IP) to its specialty academic programs. , Answering to the increasing demand ... certificate programs in health law, and environmental and land use law. ,  , ...
Breaking Medicine News(10 mins):